• Citer

Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis

par Macias, William;Vallet, Benoit;Bernard, Gordon;Vincent, Jean Louis ;Laterre, Pierre-Francois;Nelson, David;Derchak, Alexander;Dhainaut, Jean-Francois
Référence Critical care medicine, 32, 12, page (2385-2391)
Publication Publié, 2004-12

Article révisé par les pairs

• Détails

Titre:	Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis
Auteur:	Macias, William; Vallet, Benoit; Bernard, Gordon; Vincent, Jean Louis; Laterre, Pierre-Francois; Nelson, David; Derchak, Alexander; Dhainaut, Jean-Francois
Informations sur la publication:	Critical care medicine, 32, 12, page (2385-2391)
Statut de publication:	Publié, 2004-12
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Activated protein C
	Clinical trial
	Drotrecogin alfa (activated)
	Protocol
	Severe sepsis
	Xigris
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0090-3493
	info:doi/10.1097/01.CCM.0000147440.71142.AC
	info:scp/10644277923